HBCo — Hofseth Biocare ASA Cashflow Statement
0.000.00%
Last trade - 00:00- NOK614.57m
- NOK847.60m
- NOK256.34m
Annual cashflow statement for Hofseth Biocare ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -126 | -137 | -107 | -125 | -135 |
| Depreciation | |||||
| Non-Cash Items | 9.36 | 9.75 | -11.5 | 159 | 74.9 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 26 | 52.1 | 84.5 | -83.3 | 4.75 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -61.8 | -45.2 | 2.76 | -9.78 | -15.6 |
| Capital Expenditures | -37.8 | -17.8 | -14.1 | -4.07 | -26 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.188 | 0 | -0.93 | -0.001 | — |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -37.9 | -17.8 | -15 | -4.07 | -26 |
| Financing Cash Flow Items | -9.39 | -10.3 | -10.5 | -16 | -25.7 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -23.2 | 45.5 | 3.69 | 15.5 | 83.1 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -123 | -17.5 | -8.54 | 1.69 | 41.5 |